Suppr超能文献

简化的即刻启动抗逆转录病毒治疗临床算法:印度尼西亚 HATI [印度尼西亚 HIV 早期检测与治疗]实施研究。

Simplified clinical algorithm for immediate antiretroviral therapy initiation: The HATI [HIV awal (early) Test & Treat in Indonesia] implementation research in Indonesia.

机构信息

Center for Tropical Medicine; Department of Internal Medicine, Division of Tropical Medicine & Infectious Diseases, Faculty of Medicine, Public Health, & Nursing, Gadjah Mada University, Yogyakarta, Indonesia.

Center for Tropical Medicine, Gadjah Mada University, Yogyakarta, Indonesia.

出版信息

Indian J Med Res. 2022 Jun;156(6):729-741. doi: 10.4103/ijmr.ijmr_239_23.

Abstract

BACKGROUND & OBJECTIVES: Although the World Health Organization recommends same day or rapid (< seven days) antiretroviral therapy (ART) initiation, delays in ART initiation remain common due to waiting for laboratory test results. This study employed a simplified clinical algorithm the HATI [HIV Awal (Early) Test & Treat Indonesia]-SAI (Simple ART Initiation) aimed to increase the proportion of ART uptake and decrease the time to ART initiation that can be used in various care settings.

METHODS

This study compared the percentage of ART uptake and retention, viral load (VL) suppression and time to ART initiation between the observation and intervention phases among newly diagnosed HIV patients from key populations. As part of the intervention, the newly diagnosed patients underwent screening using a simple form [consisting of data on age, height and weight (for body mass index calculation), questions on the presence of symptoms of HIV stages 1 and 2, tuberculosis, history of diabetes, hypertension and kidney disease], to determine eligibility for immediate ART initiation. Those who met the pre-defined criteria immediately received a combination of tenofovir lamivudine and efavirenz for two weeks. The baseline laboratory examination due to this was moved up to two weeks post ART. Factors significantly associated with ART uptake were also determined and their odds ratios were measured using logistic regression analysis.

RESULTS

A total of 2173 people newly diagnosed with HIV were recruited, with 1579 and 594 in the observation and intervention phases, respectively. In both phases, the majority were men who have sex with men, who were young (<30 yr old) and employed, with high levels of education. The intervention phase significantly increased the proportion of ART initiation [91%, 95% confidence interval (CI): 89-93% vs. 78%, 95% CI: 76-80%] but did not have any impact on the proportion of six months retention and VL suppression. The intervention also significantly decreased the time to ART initiation from median ± interquartile range: 9±20 days to 2±10 days.

INTERPRETATION & CONCLUSIONS: The findings of this study suggest that the HATI-SAI intervention increased the uptake and decreased the time for immediate ART initiation. The HATI-SAI provides a simple and safe clinical approach that can readily be adopted in different settings without a costly investment in technology.

摘要

背景与目的

尽管世界卫生组织建议在当天或快速(<7 天)内启动抗逆转录病毒治疗(ART),但由于等待实验室检测结果,ART 启动仍普遍延迟。本研究采用简化的临床算法 HATI[HIV Awal(早期)Test & Treat Indonesia]-SAI(简单 ART 启动),旨在提高接受 ART 的比例,并缩短启动 ART 的时间,该算法可用于各种护理环境。

方法

本研究比较了新诊断的 HIV 患者在观察期和干预期之间接受 ART 的比例和保留率、病毒载量(VL)抑制率和启动 ART 的时间。在干预措施中,新诊断的患者使用简单的表格(包括年龄、身高和体重的数据(用于计算体重指数)、关于 HIV 1 期和 2 期症状、结核病、糖尿病、高血压和肾病史的问题)进行筛查,以确定是否符合立即开始 ART 的标准。那些符合预定义标准的患者立即接受替诺福韦拉米夫定和依非韦伦治疗两周。因此,基线实验室检查推迟到 ART 后两周进行。还确定了与接受 ART 显著相关的因素,并使用逻辑回归分析测量其优势比。

结果

共招募了 2173 名新诊断的 HIV 患者,观察期和干预期分别为 1579 人和 594 人。在两个阶段,大多数都是男男性行为者,他们都很年轻(<30 岁)、有工作、教育程度高。干预阶段显著提高了接受 ART 的比例[91%,95%置信区间(CI):89-93% vs. 78%,95% CI:76-80%],但对六个月的保留率和 VL 抑制率没有任何影响。干预还显著缩短了从中位数±四分位距(IQR)的启动 ART 的时间:9±20 天至 2±10 天。

结论

本研究结果表明,HATI-SAI 干预措施提高了接受 ART 的比例,并缩短了立即开始 ART 的时间。HATI-SAI 提供了一种简单且安全的临床方法,无需在技术上进行昂贵的投资,即可在不同环境中轻松采用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/10278919/4f36b9616290/IJMR-156-729-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验